Skip to main content
. 2012 Oct 8;7(10):e47289. doi: 10.1371/journal.pone.0047289

Table 2. Distribution of HIV-1 genotypes in different risk groups in China*.

HIV-1 genotype Risk group Total (%)
IDU (%) Heterosexual (%) MSM (%) FPD+BT (%) MCT (%) Other (%) N/A (%)
CRF07_BC 8,344 (48.5)[68.8] 2595 (21.9)[21.4] 62(8.8)[0.5] 43 (3.3)[0.4] 54 (18.2)[0.4] 99 (78.0)[0.8] 925 (34.7)[7.6] 12122 (35.5)[100.0]
CRF08_BC 4064 (23.6)[59.0] 2082(17.6)[30.2] 4 (0.6)[0.1] 0 (0.0)[0.0] 74 (25.0)[1.1] 9 (7.1)[0.1] 659 (24.7)[9.6] 6892 (20.2)[100.0]
CRF01_AE 3649 (21.2)[38.9] 4709 (39.8)[50.2] 392 (55.8)[4.2] 41 (3.1)[0.4] 37 (12.5)[0.4] 3(2.4)[0.0] 557 (20.9)[5.9] 9388 (27.5)[100.0]
B' 380(2.2)[11.6] 1373 (11.6)[41.7] 44 (6.3)[1.3] 1214 (92.5)[36.9] 101 (34.1)[3.1] 0 (0.0)[0.0] 177 (6.6)[5.4] 3289 (9.6)[100.0]
A 0 (0.0)[0.0] 20 (0.2)[100.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 20 (0.1)[100.0]
B 0 (0.0)[0.0] 64 (0.5)[17.9] 151 (21.5)[42.3] 15 (1.1)[4.2] 0 (0.0)[0.0] 16 (12.6)[4.5] 111 (4.2)[31.1] 357 (1.0)[100.0]
C 135 (0.8)[25.4] 287 (2.4)[54.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 109 (4.1)[20.5] 531 (1.6)[100.0]
G 0 (0.0)[0.0] 10 (0.1)[100.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 10 (0.0)[100.0]
CRF02_AG 0 (0.0)[0.0] 22 (0.2)[68.8] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 10 (0.4)[31.3] 32 (0.1)[100.0]
CRF06_cpx 0 (0.0)[0.0] 3 (0.0)[100.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 3 (0.0)[100.0]
BC 322 (1.9)[51.0] 236(2.0)[37.4] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 0 (0.0)[0.0] 73 (2.7)[11.6] 631 (1.8)[100.0]
Other discordant genotypes 302(1.8)[34.6] 444 (3.7)[50.9] 49 (7.0)[5.6] 0 (0.0)[0.0] 30 (10.1)[3.4] 0 (0.0)[0.0] 48 (1.8)[5.5] 873 (2.6)[100.0]
Total 17196 (100.0)[50.4] 11845 (100.0)[34.7] 702 (100.0)[2.1] 1313 (100.0)[3.8] 296 (100.0)[0.9] 127 (100.0)[0.4] 2669 (100.0)[7.8] 34148 (100.0)[100.0]
*

Numbers in parentheses and square brackets indicate the proportion of the HIV-infected in each subgroup as a percentage of the national total for that risk group and genotype, respectively. The estimation was done, assuming that HIV case reports reflect the actual prevalence of HIV infection in the respective risk groups and provinces (see Methods).